SELLAS Life Sciences (SLS) Acquisitions (2013 - 2014)
SELLAS Life Sciences (SLS) reported Acquisitions of $100000.0 for Q4 2014, down 67.21% quarter-over-quarter from $305000.0 in Q2 2014.
SELLAS Life Sciences (SLS) Acquisitions (2013 - 2014) Analysis & Trends
SELLAS Life Sciences (SLS) has 2 years of Acquisitions data on file, last reported at $100000.0 in Q4 2014.
- Acquisitions for Q4 2014 came in at $100000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2015 was $100000.0 (down 95.68% YoY), and the FY2017 annual result was $12.2 million, changed N/A from the prior year.
- Acquisitions declined to $100000.0 in Q4 2014 per SLS's latest filing, from $305000.0 in the prior quarter.
- Over five years, Acquisitions peaked at $10.1 million in Q1 2013 and troughed at $83000.0 in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | - |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.34 Bn | 1.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 100,000.00 |
| Jun 30, 2014 | 305,000.00 |
| Mar 31, 2014 | 2.01 Mn |
| Sep 30, 2013 | 10.00 Mn |
| Jun 30, 2013 | 83,000.00 |
| Mar 31, 2013 | 10.09 Mn |